Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis

BACKGROUND: Sulfonylurea (SU) is a commonly used antidiabetic drugs effective for type 2 diabetes mellitus. Previous studies have reported that the SU treatment could alter the serum free fatty acid (FFA) concentration in diabetic patients; however, their exact effects remain unknown. AIM: To assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ming, Feng, Xiao-Yu, Yao, Shuai, Wang, Chang, Yang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477688/
https://www.ncbi.nlm.nih.gov/pubmed/36159441
http://dx.doi.org/10.12998/wjcc.v10.i26.9524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477688/
https://www.ncbi.nlm.nih.gov/pubmed/36159441
http://dx.doi.org/10.12998/wjcc.v10.i26.9524

Ejemplares similares